Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L DeVane

Showing results (81-90 of 145) with videos related to

Pageof 15
Sort By:
Journal of Clinical Psychopharmacology|October 11, 2001
Drug glucuronidation in clinical psychopharmacologyH L Liston, J S Markowitz, C L DeVane
Journal of Toxicology. Clinical Toxicology|May 1, 1982
Hemoperfusion for imipramine overdose: elimination of active metabolitesP R Pentel, M L Bullock, C L DeVane
Psychopharmacology Bulletin|January 1, 1991
Dosage regimen design for cyclic antidepressants: a review of pharmacokinetic methodsC L DeVane, M V Rudorfer, W Z Potter
Clinical Neuropharmacology|January 1, 1992
Steady-state predictions based on first dose dataW Z Potter, C L DeVane, M V Rudorfer
Journal of Applied Microbiology|July 22, 2005
Genotypic characterization of bacteria cultured from duck faecesJ Murphy, M L Devane, B Robson, et al.
The Journal of Clinical Psychiatry|April 1, 1982
Toxic hepatitis and single daily dosage imipramine therapyR Moskovitz, C L DeVane, R Harris, et al.
Clinical Pharmacology and Therapeutics|October 1, 1991
Influence of menstrual cycle and gender on alprazolam pharmacokineticsC Kirkwood, A Moore, P Hayes, et al.
Developmental Pharmacology and Therapeutics|January 1, 1991
Disposition of cocaine in pregnant sheep. II. Physiological responsesD J Burchfield, R M Abrams, R Miller, et al.
The Journal of Clinical Psychiatry|August 24, 1999
Mirtazapine in major depression with comorbid generalized anxiety disorderP J Goodnick, A Puig, C L DeVane, et al.
Die Pharmazie|March 28, 2009
The psychostimulant d-threo-(R,R)-methylphenidate binds as an agonist to the 5HT(1A) receptorJ S Markowitz, C L DeVane, S Ramamoorthy, et al.
Pageof 15

Showing results (81-90 of 145) with videos related to

Sort By:
Pageof 15
Journal of Clinical Psychopharmacology|October 11, 2001
Drug glucuronidation in clinical psychopharmacologyH L Liston, J S Markowitz, C L DeVane
Journal of Toxicology. Clinical Toxicology|May 1, 1982
Hemoperfusion for imipramine overdose: elimination of active metabolitesP R Pentel, M L Bullock, C L DeVane
Psychopharmacology Bulletin|January 1, 1991
Dosage regimen design for cyclic antidepressants: a review of pharmacokinetic methodsC L DeVane, M V Rudorfer, W Z Potter
Clinical Neuropharmacology|January 1, 1992
Steady-state predictions based on first dose dataW Z Potter, C L DeVane, M V Rudorfer
Journal of Applied Microbiology|July 22, 2005
Genotypic characterization of bacteria cultured from duck faecesJ Murphy, M L Devane, B Robson, et al.
The Journal of Clinical Psychiatry|April 1, 1982
Toxic hepatitis and single daily dosage imipramine therapyR Moskovitz, C L DeVane, R Harris, et al.
Clinical Pharmacology and Therapeutics|October 1, 1991
Influence of menstrual cycle and gender on alprazolam pharmacokineticsC Kirkwood, A Moore, P Hayes, et al.
Developmental Pharmacology and Therapeutics|January 1, 1991
Disposition of cocaine in pregnant sheep. II. Physiological responsesD J Burchfield, R M Abrams, R Miller, et al.
The Journal of Clinical Psychiatry|August 24, 1999
Mirtazapine in major depression with comorbid generalized anxiety disorderP J Goodnick, A Puig, C L DeVane, et al.
Die Pharmazie|March 28, 2009
The psychostimulant d-threo-(R,R)-methylphenidate binds as an agonist to the 5HT(1A) receptorJ S Markowitz, C L DeVane, S Ramamoorthy, et al.
Pageof 15